CasNo.669076-03-3,JNJ26076713,3-Quinolinepropanoic acid, 1,2,3,4-tetrahydro-beta-((1-(1-oxo-3-(1,5,6,7-tetrahydro-1,8-naphthyridin-2-yl)propyl)-4-piperidinyl)methyl)-, (betaS,3S)-(669076-03-3) Suppliers

0	Negotiable

Min.Order :0
Purity: 98%

Keywords

JNJ26076713 JNJ-26076713

Quick Details

Appearance:Solid powder
Application:JNJ26076713 is an orally active alpha V integrin antagonist. It may be a potential therapeutic candidate for the treatment of age-related macular degeneration,proliferative diabetic retinopathy an...
PackAge:inquiry
ProductionCapacity:
Storage:-20°C Freezer
Transportation:inquiry

Superiority:

BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.

Details:

JNJ26076713 may be a potential therapeutic candidate for the treatment of age-related macular degeneration,proliferative diabetic retinopathy and macular edema.